TOKYO -- China's hunger for infrastructure investment helped create some of the biggest gainers in the A300 rankings, while Indian pharmaceutical companies dropped significantly as they wrestled with regulatory scrutiny and price competition in the U.S.
Bumi Serpong Damai, Indonesia's largest property developer by market capitalization, reported a net profit of 4.92 trillion rupiah ($342.7 million) last year, a 173% increase from a year earlier. That catapulted the company -- which is tied to Indonesia’s powerful Widjaja family -- from 35th in the 2016 rankings to third place.
